CEBPB and neoplasm: gRNA-Cebpb BMDCs recovered from the LN of B16-OVA, but not from the LN of B16 tumor-bearing mice, were superior in activating OT-I T cells in vitro (Fig. 2j–l) compared to gRNA-NT BMDCs.